These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 2849677

  • 1. Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine.
    el-Fakahany EE, Surichamorn W, Amrhein CL, Stenstrom S, Cioffi CL, Richelson E, McKinney M.
    J Pharmacol Exp Ther; 1988 Dec; 247(3):934-40. PubMed ID: 2849677
    [Abstract] [Full Text] [Related]

  • 2. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
    McKinney M, Stenstrom S, Richelson E.
    Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
    [Abstract] [Full Text] [Related]

  • 3. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites.
    Cioffi CL, el-Fakahany EE.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):916-23. PubMed ID: 3018226
    [Abstract] [Full Text] [Related]

  • 4. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
    Brown JH, Goldstein D, Masters SB.
    Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
    [Abstract] [Full Text] [Related]

  • 5. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115): cyclic GMP formation is mediated by a low affinity agonist-receptor conformation and cyclic AMP reduction is mediated by a high affinity agonist-receptor conformation.
    McKinney M, Richelson E.
    Mol Pharmacol; 1986 Sep; 30(3):207-11. PubMed ID: 3018477
    [Abstract] [Full Text] [Related]

  • 6. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
    McKinney M, Stenstrom S, Richelson E.
    Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
    [Abstract] [Full Text] [Related]

  • 7. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J, Chuang DM.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [Abstract] [Full Text] [Related]

  • 8. Phorbol ester-induced inhibition of cyclic GMP formation mediated by muscarinic receptors in murine neuroblastoma cells.
    Lai WS, el-Fakahany EE.
    J Pharmacol Exp Ther; 1987 May; 241(2):366-73. PubMed ID: 3033212
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Apparent noncompetitive antagonism of muscarinic receptor mediated Ca2+ mobilization by some muscarinic antagonists.
    Kukkonen J, Akerman KE.
    Biochem Biophys Res Commun; 1992 Dec 15; 189(2):919-24. PubMed ID: 1472064
    [Abstract] [Full Text] [Related]

  • 14. Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis.
    Masters SB, Quinn MT, Brown JH.
    Mol Pharmacol; 1985 Mar 15; 27(3):325-32. PubMed ID: 2983182
    [Abstract] [Full Text] [Related]

  • 15. Application of transfected cell lines in studies of functional receptor subtype selectivity of muscarinic agonists.
    Wang SZ, el-Fakahany EE.
    J Pharmacol Exp Ther; 1993 Jul 15; 266(1):237-43. PubMed ID: 7687290
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.
    Christopoulos A, Pierce TL, Sorman JL, El-Fakahany EE.
    Mol Pharmacol; 1998 Jun 15; 53(6):1120-30. PubMed ID: 9614217
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological analysis of the novel mode of interaction between xanomeline and the M1 muscarinic acetylcholine receptor.
    Christopoulos A, Parsons AM, El-Fakahany EE.
    J Pharmacol Exp Ther; 1999 Jun 15; 289(3):1220-8. PubMed ID: 10336509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.